Modified agar dilution susceptibility testing method for determining in vitro activities of antifungal agents, including azole compounds.
In vitro activities of antifungal agents, including azole compounds, against yeasts were easily determined by using RPMI-1640 agar medium and by incubating the plates in the presence of 20% CO2. The end point of inhibition was clear by this method, even in the case of azole compounds, because of the almost complete inhibition of yeast growth at high concentrations which permitted weak growth of some Candida strains by traditional methods. MICs obtained by the agar dilution method were similar to those obtained by the broth dilution method proposed by the National Committee for Clinical Laboratory Standards.
Yoshida
T
T
Analytical Department II, Takeda Analytical Research Laboratories, Ltd., Yodogawaku, Osaka, Japan.
Jono
K
K
Okonogi
K
K
D000935:Antifungal Agents / Q000494:pharmacology*; D001393:Azoles / Q000494:pharmacology*; D002175:Candida / Q000187:drug effects; D015169:Colony Count, Microbial; D003455:Cryptococcus neoformans / Q000187:drug effects; D015725:Fluconazole / Q000494:pharmacology; D008826:Microbial Sensitivity Tests; D012441:Saccharomyces cerevisiae / Q000187:drug effects
D000935:Antifungal Agents; D001393:Azoles; D015725:Fluconazole